The present invention relates to a mutated gene coding for a mutant LAT
protein leading to exaggerated T.sub.H2 differentiation. The invention
relates to biological structures containing the mutant, particularly
non-human LAT gene, mutated animals, plasmids, chromosomal DNAs, embryos
comprising the mutated gene, and applications thereof. The invention
further relates to screening methods for drugs useful for treatment
against asthma and allergy. Otherwise, the invention relates to methods
for producing IgE antibodies.